In a regulatory filing, Opko Health (OPK) disclosed that its CEO Phillip Frost bought 200K shares of common stock on March 17th in a total transaction size of $348K. Shares are up 3% at $1.87.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPK:
- Opko Health, Entera Bio enter collaboration agreement for GLP-1/glucagon peptide
- Opko Health, Entera Bio enter into collaboration agreement
- Opko Health’s Strategic Moves and Growth Potential: Buy Rating Affirmed by Maury Raycroft
- Opko Health’s Strategic Divestiture and Financial Outlook Justifies Buy Rating
- OPKO Health’s Strategic Divestiture and Focus on Core Competencies Earns Buy Rating